Charles Landis
University of Washington(US)
Publications by Year
Research Areas
Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Hepatitis B Virus Studies, Liver Diseases and Immunity
Most-Cited Works
- → Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease(2015)798 cited
- → Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection(2017)559 cited
- → Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence(2016)457 cited
- → The hepatic stem cell niche: Identification by label-retaining cell assay(2008)270 cited
- → The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis(2019)251 cited
- → Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo(1999)219 cited
- → Determination of the MRI contrast agent concentration time course in vivo following bolus injection: Effect of equilibrium transcytolemmal water exchange(2000)210 cited
- → Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit(2015)209 cited
- → Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment(2017)201 cited
- → Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial(2018)178 cited